Filing Details
- Accession Number:
- 0000950117-12-000870
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-06-29 18:46:09
- Reporting Period:
- 2012-06-27
- Filing Date:
- 2012-06-29
- Accepted Time:
- 2012-06-29 18:46:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1420720 | Ibio Inc. | IBIO | Pharmaceutical Preparations (2834) | 262797813 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1053310 | Gerald E Kay | Integrated Biopharma, Inc. 225 Long Avenue, Bldg. 15 Hillside NJ 07205 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-06-27 | 150,000 | $0.76 | 4,119,803 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Shares disposed of in connection with a refinancing transaction involving Integrated BioPharma, Inc., the former parent company of the Issuer. The Reporting Person has no present intent to dispose of additional shares.